DUBLIN–(BUSINESS WIRE)–The “Blood And Blood Components Global Market Report 2022, By Product, By End-Users, By Application, By Blood Components” report has been added to ResearchAndMarkets.com’s offering.
The global blood and blood components market is expected to grow from $35.63 billion in 2021 to $37.18 billion in 2022 at a compound annual growth rate (CAGR) of 4.4%. The market is expected to reach $44.11 billion in 2026 at a CAGR of 4.4%.
The growing prevalence of diseases and increasing numbers of road accidents and traumas are increasing the demand for blood and thus driving the market. According to a report by Centers for Disease Control and Prevention, Hemophilia A affects one out of every 5,000 male babies born. Every year, about 400 newborns are born with haemophilia A . Also, as per US NIH data, in 2019, traumatic injury was found to be the foremost reason of mortality among 1-40 years old people.
The blood and blood components market is restrained by the growing risk of developing or transferring an infection while the blood is transmitted to the patients. The growing possibilities of developing any transfusion transmitted infection (TTI) is imposing a restriction on the growth of the market.
The fear of transfusion of diseases from the donor to the recipient, forces many customers to avoid using donated blood, thus hampering the growth of the blood and blood components market. The most common viral agents that can be transmitted through blood transfusion are Human Immunodeficiency Virus (HIV), hepatitis viruses, West Nile Virus (WNV), Human T-cell Lymphotrophic Viruses (HTLVs).
The most prominent trend that has been witnessed in the blood and blood components market is the growing number of collaborations between the players involved in the market. Companies are adopting partnerships and collaborations in order to expand their reach, increase customer base and generate awareness in the market.
The blood and blood components market in European Union is governed by Directive 2002/98/EC of the EU regulations. The regulatory body engages itself in providing guidelines and setting standards for quality and safety of collection, testing, processing, storage, and distribution of blood and blood components. These guidelines ensure greater quality and safety of whole blood and its components to prevent transmission of diseases and also highlight necessary measures for their collection and distribution.
Scope
Markets Covered:
1) By Product: Whole Blood; Blood Components
2) By End-Users: Hospitals; Ambulatory Surgical Centers; Others
3) By Application: Anemia; Trauma & Surgery; Cancer Treatment; Bleeding Disorders
4) By Blood Components: Red blood cells; Platelets; Plasma; White blood cells
Key Topics Covered:
1. Executive Summary
2. Blood And Blood Components Market Characteristics
3. Blood And Blood Components Market Trends And Strategies
4. Impact Of COVID-19 On Blood And Blood Components
5. Blood And Blood Components Market Size And Growth
6. Blood And Blood Components Market Segmentation
7. Blood And Blood Components Market Regional And Country Analysis
8. Asia-Pacific Blood And Blood Components Market
9. China Blood And Blood Components Market
10. India Blood And Blood Components Market
11. Japan Blood And Blood Components Market
12. Australia Blood And Blood Components Market
13. Indonesia Blood And Blood Components Market
14. South Korea Blood And Blood Components Market
15. Western Europe Blood And Blood Components Market
16. UK Blood And Blood Components Market
17. Germany Blood And Blood Components Market
18. France Blood And Blood Components Market
19. Eastern Europe Blood And Blood Components Market
20. Russia Blood And Blood Components Market
21. North America Blood And Blood Components Market
22. USA Blood And Blood Components Market
23. South America Blood And Blood Components Market
24. Brazil Blood And Blood Components Market
25. Middle East Blood And Blood Components Market
26. Africa Blood And Blood Components Market
27. Blood And Blood Components Market Competitive Landscape And Company Profiles
28. Key Mergers And Acquisitions In The Blood And Blood Components Market
29. Blood And Blood Components Market Future Outlook and Potential Analysis
30. Appendix
Companies Mentioned
- American Red Cross
- Australian Red Cross Blood Service
- Abbott Laboratories
- Blood Centers of America
- Becton
- Dickinson & Co.
- German Red Cross
- Nipro Medical Corporation
- American Association of Blood Banks
- AVIS National
- National Blood Authority Australia
- Vitalant
- Baxter International Inc.
- CSL Behring
- Immucor
- Novartis
- Novo Nordisk
- Ortho Clinical Diagnostics
- Roche Diagnostics
- Grifols International SA
- Medimmune (AstraZeneca)
- Fresenius Kabi
- Macopharma
- Sarstedt AG & Co.
- Thermo Fisher Scientific Inc.
- Terumo Corporation
- Sarstedt AG & Co.
- Haemonetics Corporation
- Medtronic Plc.
For more information about this report visit https://www.researchandmarkets.com/r/uytx9
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
